binding buffer (Yeasen Biotechnology)
Structured Review
Binding Buffer, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/binding+buffer/1x+binding+buffer/pm42048041-77-21-23
Average 86 stars, based on 1 article reviews
Images
Related Articles
Binding Assay:Article Title: Cinobufagin suppresses T-ALL via USP7-Mediated inhibition of NOTCH1/PI3K signaling pathways. Article Snippet: T-cell acute lymphoblastic leukemia (T-ALL) is a highly heterogeneous disease which has low survival rate and liable to recurrence.. Cinobufagin (CBG) is an active ingredient extracted from traditional Chinese medicine ChanSu, which exerts inhibitory effect in various cancers.. However, the therapeutic effect of CBG on T-ALL remains still unknown. Article Title: PLEKHA4 knockdown induces apoptosis in melanoma cells through the MAPK and β‑catenin signaling pathways. Article Snippet: Malignant melanoma (MM) is a highly aggressive subtype of skin cancer characterized by a poor prognosis, particularly in the advanced stages. despite advancements in targeted therapy and immunotherapy, the survival rates for MM remain low, underscoring the need for new therapeutic targets.. Pleckstrin homology domain‐containing family a member 4 (PleKHa4), which has regulatory functions in pivotal cellular processes, has emerged as a potential target in melanoma.. The present study aimed to investigate the role of PLEKHA4 in melanoma progression, focusing on its influ‐ ence on the MaPK and Wnt/β‐catenin signaling pathways. Article Title: PLEKHA4 upregulation regulates KIRC cell proliferation through β‑catenin signaling Article Snippet: The cells were then incubated with RNase A and PI Staining Solution (Shanghai Yeasen Biotechnology Co., Ltd.) in the dark at room temperature for 10–15 min. .. Finally, 400 μl Article Title: Squalene attenuates doxorubicin resistance in hepatocellular carcinoma by targeting SIRT6 to inhibit ERK1 deacetylation. Article Snippet: .. After carefully removing the supernatant, the cell pellet was washed twice with pre-cooled PBS and suspended in 300 μL of 1× Article Title: PLEKHA4 upregulation regulates KIRC cell proliferation through β‑catenin signaling Article Snippet: .. Cells were then washed twice with pre-cooled PBS and resuspended in 100 μl Article Title: ABCC9 knockdown attenuates isoproterenol-induced myocardial hypertrophy by inhibiting the PI3K/AKT signaling pathway Article Snippet: .. In addition, the cells were incubated with 100 μl Article Title: Co-delivery of panobinostat and siSTAT3 using engineered M1 exosomes to establish a one-two punch therapeutic strategy for glioblastoma recurrence Article Snippet: .. 5 × 10 5 cells were resuspended by adding 100 μL 1 × Staining:Article Title: PLEKHA4 knockdown induces apoptosis in melanoma cells through the MAPK and β‑catenin signaling pathways. Article Snippet: Malignant melanoma (MM) is a highly aggressive subtype of skin cancer characterized by a poor prognosis, particularly in the advanced stages. despite advancements in targeted therapy and immunotherapy, the survival rates for MM remain low, underscoring the need for new therapeutic targets.. Pleckstrin homology domain‐containing family a member 4 (PleKHa4), which has regulatory functions in pivotal cellular processes, has emerged as a potential target in melanoma.. The present study aimed to investigate the role of PLEKHA4 in melanoma progression, focusing on its influ‐ ence on the MaPK and Wnt/β‐catenin signaling pathways. Incubation:Article Title: PLEKHA4 knockdown induces apoptosis in melanoma cells through the MAPK and β‑catenin signaling pathways. Article Snippet: Malignant melanoma (MM) is a highly aggressive subtype of skin cancer characterized by a poor prognosis, particularly in the advanced stages. despite advancements in targeted therapy and immunotherapy, the survival rates for MM remain low, underscoring the need for new therapeutic targets.. Pleckstrin homology domain‐containing family a member 4 (PleKHa4), which has regulatory functions in pivotal cellular processes, has emerged as a potential target in melanoma.. The present study aimed to investigate the role of PLEKHA4 in melanoma progression, focusing on its influ‐ ence on the MaPK and Wnt/β‐catenin signaling pathways. Article Title: ABCC9 knockdown attenuates isoproterenol-induced myocardial hypertrophy by inhibiting the PI3K/AKT signaling pathway Article Snippet: .. In addition, the cells were incubated with 100 μl |

